Abstract-In the present study, we differentiated between short-and long-term effects of vasoactive compounds on human endothelial permeability in an in vitro model. Histamine induced a rapid and transient (Ͻ3 minutes) decrease in barrier function, as evidenced by a decreased transendothelial electrical resistance and an increased passage of 22 Na ions. This increase in permeability was inhibited completely by chelation of intracellular calcium ions by BAPTA-AM and inhibition of calmodulin activity and myosin light chain (MLC) phosphorylation. The presence of serum factors prolonged the barrier dysfunction induced by histamine. Thrombin by itself induced a prolonged barrier dysfunction (Ͼ30 minutes) as evidenced by an increased passage of peroxidase and 40 kDa dextran. It was dependent only partially on calcium ions and calmodulin. The protein tyrosine kinase inhibitors genistein and herbimycin A, but not the inactive analogue daidzein, inhibited to a large extent the increase in permeability induced by thrombin. Genistein and BAPTA-AM inhibited the thrombin-induced permeability in an additive way, causing together an almost complete prevention of the thrombin-induced increase in permeability. Inhibition of protein tyrosine kinase was accompanied by a decrease in MLC phosphorylation and a reduction in the extent of F-actin fiber and focal attachment formation. Inhibition of RhoA by C3 transferase toxin reduced both the thrombin-induced barrier dysfunction and MLC phosphorylation. Genistein and C3 transferase toxin did not elevate the cellular cAMP levels. No evidence was found for a significant role of protein kinase C in the thrombin-induced increase in permeability or in the accompanying MLC phosphorylation. These data indicate that in endothelial cell monolayers that respond to histamine in a physiological way, thrombin induces a prolonged increase in permeability by "calcium sensitization," which involves protein tyrosine phosphorylation and RhoA activation. (Circ Res. 1998;83:1115-1123.) Key Words: human endothelial cell Ⅲ RhoA Ⅲ protein tyrosine kinase Ⅲ protein kinase C T he endothelium is the main physical barrier in the extravasation of blood components to the surrounding tissue. Impairment of this barrier leads to an increase in permeability and formation of edema. Inflammatory mediators such as histamine, bradykinin, and substance P cause a rapid transient increase in permeability in vivo, which results from a rapid formation of endothelial gaps especially in the postcapillary venules.
T he endothelium is the main physical barrier in the extravasation of blood components to the surrounding tissue. Impairment of this barrier leads to an increase in permeability and formation of edema. Inflammatory mediators such as histamine, bradykinin, and substance P cause a rapid transient increase in permeability in vivo, which results from a rapid formation of endothelial gaps especially in the postcapillary venules. 1, 2 These gaps are thought to be due to endothelial cell (EC) contraction, a process that involves actin nonmuscle myosin interaction, and requires Ca 2ϩ , calmodulin (CaM) and ATP, and the phosphorylation of the myosin light chain (MLC). [3] [4] [5] This process is regulated by Ca 2ϩ /CaMdependent protein kinase I, the classic MLC kinase. 4 , 5 Baluk et al 1 recently have shown that the half-life of the gaps induced by substance P in healthy rat tracheal venules is Ͻ2 minutes and that the presence of these gaps runs parallel to the increase in endothelial permeability. In frog mesenterium microvessels, a similar temporal relationship was found between the transient increase in cytoplasmic Ca 2ϩ ions and the increase in endothelial permeability after stimulation with histamine. 6 Additional mechanisms must occur to explain the prolonged vascular leakage that contributes to clinical forms of serious edema. These mechanisms include multiple release of vasoactive agents, endothelial binding and activation of leukocytes, 7 and, occasionally, the participation of segments of the vascular bed other than postcapillary venules. 8, 9 In these circumstances, the endothelial barrier function is reduced by an interplay between actin nonmuscle myosin interaction, 4 ,5 disintegration of endothelial junctions, 10 and the formation of inter-and occasionally intracellular pores. [11] [12] [13] However, the molecular mechanisms regulating prolonged leakage are still poorly understood.
ECs in vitro are helpful in providing biochemical information regarding molecular mechanisms contributing to endothelial permeability. 4, 5 Most information has been obtained using thrombin, a stimulus that induces a prolonged increase in permeability in endothelial monolayers, 14 similar to the effect it elicits in vivo. 15 In contrast to the transient effect of histamine and other vasoactive agents, the reduction of endothelial barrier function induced by thrombin extends over 1 hour and is far beyond the transient rise in cytoplasmic Ca 2ϩ concentration that closely accompanies the leakage induced by histamine. 16 Several authors have already pointed out additional factors that influence endothelial permeability other than the Ca 2ϩ /CaM-dependent phosphorylation of the MLC. These factors include activation of protein kinase C (PKC) 17, 18 and inhibition of MLC phosphatase. 19, 20 In this study, we investigated which pathways are involved in the different permeability-increasing effects of histamine and thrombin and provide evidence for the involvement of protein tyrosine phosphorylation and RhoA in addition to the Ca 2ϩ / CaM-dependent phosphorylation of MLC in the thrombininduced permeability of these human endothelial monolayers.
The in vitro models frequently have been considered inadequate because most studies are limited to prolonged increases in endothelial permeability. Therefore, we also present data on the effect of histamine on human endothelial monolayers. Under the proper conditions, the response to histamine is identical as observed in postcapillary venules in vivo; its size and duration can be influenced by exposure of the cells to endotoxin or serum factors.
Materials and Methods

Materials
Tissue culture plastics and Transwells (diameter, 0.65 cm; pore size, 3 m) were obtained from Costar; cell culture reagents were obtained as previously described. 21 Human serum was obtained from the local blood bank and was prepared from fresh blood taken from healthy donors; this was pooled, heat-inactivated (30 minutes; 56°C), and stored at 4°C. Heat-inactivated newborn calf serum (NBCS) was obtained from Gibco BRL. Bovine thrombin (5000 NIH units) was from Leo Pharmaceutical Products. Fluorescein isothiocyanate-labeled dextran (molecular mass, 40 kDa), histamine, horseradish peroxidase (HRP), LPS from E. coli serotype O128:B12, phorbol 12-myristate-13-acetate (PMA), trifluoperazine (TFP), and anti-vinculin Ig were obtained from Sigma Chemical Co. BAPTA-AM and rhodamine phalloidin were from Molecular Probes. ML-7 was from Calbiochem Novabiochem Corporation. Calphostin C, genistein, herbimycine A, 1-oleoyl-2-acetylglycerol, thymeleatoxin and tyrphostin A47 were from Alexis Inc. Ranitidine, dimaprit, R-␣-methylhistamine, and d-neobenodine were a kind gift from Professor H. Timmerman (Free University Amsterdam, the Netherlands). Ro31-8220 was a kind gift from Dr P.A. Brown (Roche Products Ltd, Welwyn Garden City, UK). C3 transferase toxin was kindly provided by Dr A. Ridley (Ludwig Institute, London, UK). S label were from ICN Pharmaceuticals Inc. Anti-platelet myosin Ig (nonmuscle) was from Sanbio. Rabbit anti-mouse IgG-fluorescein isothiocyanate was from Dakopatts. 22 Na as sodium chloride was from Amersham Lifescience.
Evaluation of the Barrier Function
Human umbilical vein ECs (HUVEC) were isolated and cultured as previously indicated. 21 For the evaluation of the barrier function, confluent monolayers of HUVEC (first and second passage) were released with trypsin-EDTA and seeded in high density on fibronectin-coated polycarbonate filters of the Transwell system and cultured. Medium was renewed every other day. Monolayers were used between 4 and 6 days after seeding. Exchange of macromolecules through the endothelial monolayers was investigated by assay of the transfer of HRP or dextran-fluorescein isothiocyanate and was performed as described previously. 21 All passage experiments were performed in triplicate.
Passage of 22 Na, diluted in Medium 199 to 1% HSA to give a specific activity of 1250 cpm/g, through EC monolayers was examined in a similar way. Passage of 22 Na was represented as a difference of histamine-induced and basal passage of 22 Na and was expressed in cpm/well.
Transendothelial Electrical Resistance
Transendothelial electrical resistance (TEER) was measured as described previously. 22 In short, an alternating current (50 A) was passed across the monolayer (2 pulses every minute). mol/L methionine, 10% human serum, 10% NBCS, 150 g/mL crude EC growth factor, 5 U/mL heparin, 100 U/mL penicillin, and 0.1 mg/mL streptomycin) for 48 hours. Cells were washed with phosphate-free buffer (in mmol/L: NaCl 119, KCl 5, glucose 5.6, MgCl 2 0.4 , CaCl 2 1, and Pipes 25; pH 7.2) and labeled with 0.5 mL 150 Ci/mL [ 32 P]orthophosphoric acid in phosphate-free buffer for 2 hours and then stimulated with histamine or thrombin. Buffer was removed, and cells were lysed by scraping in 300 L of ice-cold lysis-buffer (25 mmol/L Tris-HCl, 250 mmol/L NaCl, 75 mmol/L NaF, 5 mmol/L EGTA, 5 mmol/L EDTA, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.2 mmol/L phenylmethylsulfonyl fluoride, 0.5 mmol/L dithiothreitol, 10 g/mL aprotinin, and 100 mmol/L Na 4 P 2 O 7 ). The lysates were centrifuged for 20 minutes in an Eppendorf centrifuge. The supernatants were incubated with 6 L of polyclonal rabbit anti-platelet myosin IgG for 1 hour. Subsequently, 20 L 1:1 of prewashed protein A-Sepharose 4B was added for an additional hour. Immune complexes bound to protein A Sepharose 4B were collected by centrifugation. Pellets were washed 3 times with PBS and resolved in 50 L SDS sample buffer. The samples were electrophoresed on 16% SDS polyacrylamide gels. The gels were dried and exposed to a phosphoimaging screen. Quantitation of 32 P incorporation into MLC was performed using a Fuji BAS 1000 PhosphorImager as follows. Double-labeled samples were exposed to phosphoimaging screens directly, and the total amount of radioactivity ( 35 Sϩ 32 P) was quantitated for MLCs. A second exposure was obtained in which a filter of 4 layers of aluminum foil was present between the gel and the phosphoimaging screen to block 35 S radiation. The amount of 32 P and 35 S incorporation in the MLC band of each sample was calculated, and MLC phosphorylation was expressed as a percentage of control.
Phosphorylation of MLC
Extraction and Assay of cAMP
Intracellular cAMP levels were determined by radio-immunoassay (Amersham, Amersham, UK) as described previously.
21
Immunocytochemistry
The presence of vinculin and F-actin were visualized by indirect immunofluorescence with mouse anti-vinculin antibody (1:300) and by direct staining with rhodamine-phalloidin (1:100).
Statistical Analysis
Data are reported as meanϮSEM. Comparisons between Ͼ2 groups were made using the Kruskal-Wallis test, and individual groups comparisons were done using a Mann-Whitney test for post hoc comparisons. Comparisons of time curves of 2 groups were made using repeated measures ANOVA, and individual groups comparisons were done using a Student t test for post hoc comparisons of the means. Differences were considered significant at the PϽ0.05 level.
Results
Histamine Induces a Short-Term Decrease in Endothelial Barrier Function
In HUVEC, the addition of histamine (3ϫ10 Ϫ6 mol/L) induced a rapid decrease in the real-time TEER, which was maximal after 1 minute (72Ϯ7% compared with basal level; 5 different cultures in triplicate) and lasted for Ͻ5 minutes ( Figure 1A ). An increase in the passage of 22 Na paralleled the decrease in TEER ( Figure 1C ). The effect of histamine on TEER was mimicked by the histamine H 1 agonist thiazolylethylamine, but not by the histamine H 2 agonist dimaprit ( Figure 1B ). Preincubation for 10 minutes with the histamine H 1 antagonist d-neobenodine blocked the decrease in TEER induced by histamine, while the histamine H 2 antagonist ranitidine had no effect ( Figure 1A ).
The histamine-induced increase in EC permeability was inhibited completely by preincubation with the intracellular calcium chelator BAPTA-AM or the CaM inhibitor TFP ( Figure 1D ) and to a large part by the MLC kinase inhibitor ML-7 ( Figure 1E ). Addition of histamine to HUVEC increased MLC phosphorylation transiently (135Ϯ13% after 2 minutes; Figure 2 , F). This effect extended slightly beyond the decrease in TEER. However, part of the MLC phosphorylation was inhibitable by the protein tyrosine kinase (PTK) inhibitor genistein (30 g/mL for 1 hour). The genisteininsensitive MLC phosphorylation exactly paralleled the histamine-induced increase in permeability (Figure 2 , E), as the histamine induced decrease in TEER was completely insensitive to inhibition of PTKs with genistein ( Figure 1F ). Preincubation of the cells with C3 transferase did not affect the histamine-induced increase in permeability (see RhoA Involvement in Thrombin-Enhanced Permeability). Together, these data are consistent with a role of Ca 2ϩ /CaM-dependent and genistein-insensitive phosphorylation of MLC in the transient increase in permeability induced by histamine.
The Response of ECs to Histamine Can Be Modified
Pretreatment of HUVEC with 10 g/mL LPS for 24 hours enlarged the decrease in TEER induced by histamine ( Figure  3A ) from 79Ϯ9% to 58Ϯ5% (meanϮSEM of 3 different cultures at least in triplicate; PϽ0.001). Addition of human serum to our system considerably prolonged the response induced by histamine ( Figure 3B ).
Thrombin Induces a Prolonged Decrease in Endothelial Barrier Function That Involves PTK Activity
A prolonged response also is induced by thrombin in the absence of serum. The thrombin-induced reduction in TEER lasted for at least 30 minutes. The decrease in TEER was paralleled by a rapid increase in the passage of macromolecules, which was sustained usually for at least 1 hour, as is shown for HRP in Figure 4 .
In agreement with previous reports, 21, 25 the prolonged increase in permeability for macromolecules (HRP) induced by thrombin was inhibited partially (maximally 60%) by BAPTA-AM or by the CaM inhibitor TFP (not shown). Thus, in contrast to the transient increase in permeability induced by histamine, the prolonged increase induced by thrombin Ϫ5 mol/L histamine or were sham treated. Passage of 22 Na was expressed as a difference between histamine-stimulated and basal passage of 22 Na. Values are meanϮSEM of 2 different cultures in 6-fold. *PϽ0.05, histamineinduced versus basal 22 required additional activation or sensitization steps other than Ca 2ϩ /CaM-dependent MLC phosphorylation. Therefore, we evaluated whether inhibition of PKC or PTK affected the thrombin-induced permeability.
At 1 and 10 nmol/L, the PKC activator PMA (15 minutes' preincubation) reduced endothelial permeability by 25% to 50%, whereas at higher concentrations (100 nmol/L), which give an extreme activation of PKC compared with thrombin and histamine, it increased the permeability. In the presence of thrombin, 10 nmol/L PMA reduced the permeability in HUVEC significantly (Table) . Similarly, the PKC-activating diacylglycerol analogue 1-oleoyl-2-acetylglycerol (50 mol/L) and thymeleatoxin (10 nmol/L), which activates predominantly calciumdependent PKCs, reduced thrombin-enhanced permeability of dextran by 42Ϯ13% (nϭ7) and 44Ϯ6% (nϭ6), respectively.
Subsequently, the PKC inhibitors Ro31-8220 and Calphostin C were used. Although Ro31-8220 completely counteracted the effect of PMA, it did not alter the thrombin-induced increase in permeability (Table) . Calphostin C (100 nmol/L) slightly increased the basal permeability (from 0.82Ϯ0.17 to
), but the thrombin-stimulated permeability was not affected by 15 minutes' preincubation with Calphostin C, being 7.8Ϯ1.7 and 7.2Ϯ1.4 g ⅐ h Ϫ1 ⅐ cm
Ϫ2
, respectively (4 cultures). The phosphorylation of MLC was not affected by PMA or Ro31-8220 under thrombinstimulated conditions (Table) . These data do not support a significant role for PKC activation in thrombin-induced increase in permeability of HUVEC monolayers.
Subsequently, we studied whether inhibition of PTK prevented the thrombin-enhanced permeability. As shown in Figure 4 , preincubation of HUVEC monolayers with genistein, but not its inactive analogue daidzein (both preincubated at 30 g/mL for 1 hour) attenuated the thrombininduced HRP passage, which became significant after 5 minutes. The reduction of thrombin-induced permeability by genistein was dose-dependent (3 to 100 g/mL tested; data not shown). Preincubation with another PTK inhibitor herbimycine A (0.3 g/mL for 2 hours) resulted in a similar inhibition, whereas tyrphostin A47 (up to 10 g/mL), which has a different substrate spectrum, had no effect on the thrombin-induced HRP passage.
Genistein reduced the basal MLC phosphorylation ( Figure  5 ), parallel to its reduction of basal permeability. Thrombin induced a prolonged increase in the phosphorylation of MLC ( Figure 5 inset, F) , which was maximal 1 minute after exposure to thrombin and remained elevated for at least 30 minutes. Although the degree of MLC phosphorylation in thrombin-induced HUVEC was lower in genistein-treated cells, this decrease reflected the lower basal MLC phosphorylation state rather than the increase induced by thrombin itself ( Figure 5 inset, E) . Simultaneously, the thrombininduced decrease in TEER attenuated by 36Ϯ17% (assayed after 10 minutes; PϽ0.01; 2 experiments in 5-fold) after preincubation of 30 g/mL genistein, whereas genistein did not affect the basal TEER. When HUVEC were preincubated with genistein, the cellular cAMP concentration remained unaltered both under basal conditions (2.3Ϯ0.2 and 2.3Ϯ0.1 pmol/3.5ϫ10 5 cells in control and genistein-preincubated cells) and after 10 minutes' stimulation of the cells with 1 U/mL thrombin (3.1Ϯ0.5 and 2.9Ϯ0.3 pmol/3.5ϫ10 5 cells, respectively; 3 experiments). This excludes the possibility that genistein could act on endothelial permeability and MLC phosphorylation via elevation of the cAMP concentration. The inhibition of thrombin-induced permeability by genistein was additive to the inhibition by BAPTA-AM ( Figure 6 ). Together, these compounds caused a nearly complete prevention of the thrombin-induced permeability. They also affected the basal permeability, probably because a low degree of endothelial activation occurs even under basal conditions. These data show that Ca 2ϩ -dependent and PTK- 
PTKs Are Involved in Thrombin-Induced Cytoskeletal Rearrangements
Under basal conditions, F-actin fibers in HUVEC were arranged into a fine cortical network with a dense peripheral band evident at the cell boundaries ( Figure 7A) ; occasionally, stress fibers were observed. When the monolayers were preincubated with genistein (30 g/mL; Figure 7B ) the cells became wrinkled, the cortical actin band was less obvious, and an increase in diffuse cytoplasmic actin staining was observed. After stimulation of the cells with 1 U/mL thrombin, many stress fibers were formed ( Figure 7C) ; simultaneously, small gaps became visible at the cell-cell contact areas, and an increase in vinculin staining was observed, indicating that focal adhesion sites were formed ( Figure 7E and 7G). The thrombin-induced cytoskeletal rearrangements were inhibited largely by preincubation with genistein (Figure 7D and 7H ). This was reflected by a marked, but not complete reduction of stress fibers, a reduction of the occurrence of small gaps and a reduction in the extent of focal adhesion formation.
RhoA Involvement in Thrombin-Enhanced Permeability
Recent data pointed to a role of RhoA in the formation of stress fibers 26 and cell contraction 24, 27, 28 in nonvascular cells. Because thrombin-induced tyrosine phosphorylation may be involved in the activation of RhoA and subsequently in the regulation of stress fiber formation via RhoA, we used an inhibitor of RhoA, the toxin C3 transferase of C. botulinum to evaluate whether RhoA contributed to the thrombin-induced increase in permeability. Titration of the C3 transferase toxin revealed that 24 hours' incubation with 3 to 5 g/mL toxin caused sufficient uptake without changing the permeability of the monolayers by itself. Preincubation with 5 g/mL C3 transferase toxin markedly attenuated the thrombin-enhanced permeability as well as basal permeability ( Figure 8A ). This attenuation was accompanied by a reduced MLC phosphorylation ( Figure 8B ). The reduction in endothelial permeability by C3 transferase was abolished by heat treatment of the C3 transferase preparation (5 minutes at 95°C). Preincubation of the cells with 5 g/mL C3 transferase did not change the 
Discussion
In the present study, we have provided evidence for the involvement of PTK activity and RhoA in the prolonged thrombin-induced increase in permeability. The thrombinenhanced permeability was accompanied by an increase in MLC phosphorylation and the generation of F-actin fibers, both of which were reduced by the inhibition of PTK or RhoA. The transient increase in permeability induced by histamine was not affected by PTK or RhoA inhibition. In in vivo experiments, stimulation of healthy vessels with vasoactive agents, such as histamine, bradykinin, and substance P, induces a transient increase in permeability of postcapillary venules. 1, 2 This involves a Ca 2ϩ /CaM-dependent activation of the EC 6 and a transient formation of minute gaps at the cell-cell contacts leaking monastral blue during a period of only a few minutes. 1 In our in vitro model, the time course of the permeability increase induced by histamine is identical to the increase observed in vivo in leakage and involves a similar activation mechanism. 6 However, under many pathological conditions, massive leakage can occur over a long period of time. We have demonstrated here that the increase in endothelial permeability induced by histamine was prolonged significantly in time by the addition of serum factors. These data support the idea that additional mechanisms contribute to the prolonged vascular leakage. At this moment, the additional factor(s) in serum responsible for the prolongation of the histamine effect are not yet known. Recently, Bloemers et al 29 reported a sensitization of H 1 receptor in embryonic cells by the presence of serum and leukotrienes. Alternatively, sensitization of the Ca 2ϩ /CaMdependent activation of MLC phosphorylation, known from studies in smooth muscle cells, 28 may also contribute to the prolonged response.
The thrombin-induced increase in endothelial permeability provides a condition in which the Ca 2ϩ /CaM-dependent MLC phosphorylation is sensitized. Chelation of cytoplasmic Ca 2ϩ ions by BAPTA-AM only partially reduces the thrombin-induced increase in endothelial permeability. 21, 25 Our data show that inhibition of PTK reduces thrombininduced permeability by an additional mechanism and almost completely prevents this increase when added simultaneously with BAPTA-AM. Inhibition of PTK may act on endothelial permeability by various mechanisms. It has been shown that PTK inhibitors attenuate the agonist-induced cellular Ca 2ϩ influx. 30, 31 However, our finding that coincubation of BAPTA-AM with genistein has an additive effect suggests that activation of PTKs by thrombin involves an additional pathway. Other reports have pointed to the disruption of adherens junctions and reorganization of focal adhesion plaques by thrombin. Rabiet et al 32 found that thrombin disrupted the VE-cadherin-catenin complex in adherens junctions, which could be prevented by the PTK inhibitor herbimycin A. Schaphorst et al 33 reported the tyrosine phosphorylation of focal adhesion kinase p125 FAK , which accompanied the reorganization of focal adhesion sites induced by thrombin. These changes in cell-cell and cell-matrix interaction may contribute to the enhanced permeability induced by thrombin. Here, we show that inhibition of PTKs affects the formation of F-actin fibers and decreases the MLC phosphorylation. By these actions, it may influence the interaction of the F-actin cytoskeleton with cell-cell and cell-matrix attachment sites and reduces actin-nonmuscle myosin interaction causing local contractile forces probably in the margins of the ECs.
Another candidate molecule to be regulated by PTKs and involved in permeability is RhoA. Hippenstiel et al 34 recently have shown that RhoA plays a role in basal endothelial permeability. A well-established effect of RhoA is stress fiber formation, a process that is known to be activated by PTKs in ECs. 35 Furthermore, it is known that activation of RhoA induces MLC phosphorylation, probably via Rho kinase, which may act via inactivating the regulatory subunit of a myosin phosphatase. 36 Here, we show that inhibition of RhoA by C3 transferase attenuates both the basal and thrombininduced EC barrier dysfunction and the accompanied increase in MLC-phosphorylation. This fits with the finding that the thrombin-mediated stress fiber formation is dependent on the activation of PTKs. The function of these stress fibers is not completely understood at present. In ECs, they seem to have a protective function against fluid shear stress by developing cell tension. 37 Goeckeler and Wysolmerski 23 and Moy et al 16 have demonstrated that tensile forces are developed in thrombin-stimulated ECs, whereas these forces are insignificant in HUVEC exposed solely to histamine. In this context, it is likely that the F-actin fiber structures contribute to a state of prolonged EC contraction after thrombin challenge. Furthermore, it is known that in smooth muscle cells, activation of RhoA results in "calcium sensitization," ie, independently of a change in Ca 2ϩ , MLC phosphate levels increase by inhibition of the smooth muscle myosin phosphatase (SMPP-1) via activation of a RhoA-dependent kinase, resulting in force generation. 28 In addition to an effect of Rho kinase on the activity of myosin phosphatase 1, Rho kinase may also act itself as an MLC kinase. 36 In smooth muscle cells, the calcium sensitization is accompanied by a translocation of RhoA from the cytosol to the cell membrane. 28 Preliminary data indicate that activation of ECs by thrombin results in a similar translocation of RhoA. Verin et al 20 have shown that in ECs, the myosin phosphatase is inhibited by thrombin. Based on these observations, we suggest a model ( Figure 9 ) in which transient EC barrier failure is mediated by an activation of Ca 2ϩ /CaM-dependent protein kinase I, whereas prolongation of EC barrier dysfunction results from a sensitization of this process by a parallel activation of PTK and RhoA.
An interesting finding of this study is that although inhibition of PTKs by genistein lowers the basal MLC phosphorylation status, it does not influence the relative increase in MLC phosphorylation induced by histamine. First, this indicates that activation of the Ca 2ϩ /CaM-dependent MLC kinase by histamine is not PTK-dependent under our experimental conditions. This is confirmed by the fact that inhibition of PTKs does not affect the histamine-induced EC contraction, as measured by TEER. In addition, this finding suggests the existence of different pools of MLC. The relative increase in MLC phosphorylation that is caused by histamine is enough to induce contraction of genistein-treated ECs, although total MLC phosphorylation levels were lowered by inhibition of PTKs. Under these conditions, MLCphosphate levels did not exceed basal MLC-phosphate levels. This is of importance, because until now it was unclear how a generalized contraction of the EC could cause focal openings between the cells. One explanation may be that pools of MLCs located near the border of the cell are involved in the formation of the small gaps. These findings need further investigation.
Under our experimental conditions, we could not find evidence of an important contribution of PKC to the thrombin-induced increase in endothelial permeability of human EC. Several lines of evidence make it unlikely that PKC plays a major role in the prolonged increase in human endothelial permeability induced by thrombin. First, incubation of human EC with PMA caused a decrease in permeability at moderate concentrations (1 and 10 nmol/L), whereas the permeability increased only at very high concentrations, which give an extreme activation of PKC compared with thrombin and histamine. Second, Ro31-8220 and Calphostin C, inhibitors of PKC, did not prevent the thrombininduced increase in permeability. PMA and Ro31-8220 also had no effect on thrombin-stimulated MLC phosphorylation. Third, histamine and thrombin induce a very similar rise in intracellular Ca 2ϩ and give a comparable activation of PKC in human EC. 38, 39 For animal ECs, the role of PKC in endothelial permeability has been established by several investigators. 17, 18 However, in HUVEC, the contribution of PKC could not be demonstrated unequivocally. Yamada et al 40 showed that activation of PKC by PMA caused a decrease in endothelial permeability, whereas Bussolino et al 41 found an increase in endothelial permeability by PKC activation. Garcia et al 25 did not find any direct effect of PMA on human endothelial permeability and MLC phosphorylation, whereas they found an increase of both by PMA in bovine ECs. Therefore, it seems that species differences are responsible for the discrepancies observed between the different studies.
In conclusion, we have demonstrated that in endothelial monolayers in vitro, which give a similar transient permeability response after exposure to histamine as expected from in vivo experiments, 1 thrombin induces a prolonged increase in permeability that involves protein tyrosine phosphorylation and RhoA activation. This mechanism appears comparable to the calcium sensitization observed in smooth muscle cells. 28 Future studies have to verify its occurrence in ECs in vivo and elucidate whether a similar sensitization mechanism underlies the increased permeability that is enhanced by leukocytes and humoral factors circulating in patients with prolonged edema. . MLC phosphorylation can be prolonged by activation of RhoA in a PTKdependent way. Rho kinase probably reduces the activity of myosin phosphatase type 1. 20 In addition to an effect of Rho kinase on the activity of myosin phosphatase 1, Rho kinase itself may act also as a MLC kinase. 36 It should be noted that RhoA also is involved in the organization of the actin cytoskeleton and in cell-cell and cell-matrix interactions. PLC indicates phospholipase C; PP1 M, myosin phosphatase type 1; and MLC-P, phosphorylated MLC.
